ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $394 | -81.0% | 2,988 | -26.7% | 0.00% | – |
| Q2 2023 | $2,079 | +20.6% | 4,077 | +49.0% | 0.00% | – |
| Q1 2023 | $1,724 | -98.8% | 2,736 | -98.7% | 0.00% | – |
| Q4 2022 | $139,553 | -60.2% | 214,995 | +5.3% | 0.00% | – |
| Q3 2022 | $351,000 | +2600.0% | 204,195 | +1823.6% | 0.00% | – |
| Q2 2022 | $13,000 | -13.3% | 10,615 | -52.7% | 0.00% | – |
| Q1 2022 | $15,000 | -97.9% | 22,426 | -96.6% | 0.00% | – |
| Q4 2021 | $726,000 | -24.9% | 665,620 | +25.3% | 0.00% | -100.0% |
| Q3 2021 | $967,000 | -61.8% | 531,388 | -44.6% | 0.00% | -50.0% |
| Q2 2021 | $2,532,000 | -16.6% | 958,913 | +13.7% | 0.00% | 0.0% |
| Q1 2021 | $3,036,000 | +267.1% | 843,199 | +156.4% | 0.00% | – |
| Q4 2020 | $827,000 | +27.4% | 328,867 | +27.4% | 0.00% | – |
| Q3 2020 | $649,000 | -45.7% | 258,059 | -29.3% | 0.00% | -100.0% |
| Q2 2020 | $1,196,000 | +34.1% | 364,945 | +0.2% | 0.00% | 0.0% |
| Q1 2020 | $892,000 | -60.6% | 364,218 | -24.1% | 0.00% | 0.0% |
| Q4 2019 | $2,266,000 | -14.2% | 480,177 | -22.2% | 0.00% | 0.0% |
| Q3 2019 | $2,640,000 | -30.2% | 617,051 | -4.9% | 0.00% | -66.7% |
| Q2 2019 | $3,783,000 | +211.6% | 649,081 | +105.9% | 0.00% | – |
| Q1 2019 | $1,214,000 | +6.7% | 315,174 | -48.2% | 0.00% | -100.0% |
| Q4 2018 | $1,138,000 | -4.1% | 608,596 | +64.2% | 0.00% | 0.0% |
| Q3 2018 | $1,187,000 | +36.8% | 370,612 | +29.0% | 0.00% | 0.0% |
| Q2 2018 | $868,000 | -44.0% | 287,186 | -27.2% | 0.00% | 0.0% |
| Q1 2018 | $1,549,000 | -10.6% | 394,717 | -5.6% | 0.00% | 0.0% |
| Q4 2017 | $1,732,000 | +132.8% | 418,300 | +245.5% | 0.00% | – |
| Q3 2017 | $744,000 | -29.0% | 121,071 | -28.1% | 0.00% | – |
| Q2 2017 | $1,048,000 | +59.0% | 168,476 | +61.9% | 0.00% | – |
| Q1 2017 | $659,000 | -65.6% | 104,035 | -70.9% | 0.00% | -100.0% |
| Q4 2016 | $1,916,000 | +361.7% | 358,086 | +386.8% | 0.00% | – |
| Q3 2016 | $415,000 | -32.8% | 73,559 | -34.6% | 0.00% | – |
| Q2 2016 | $618,000 | -66.3% | 112,477 | -54.4% | 0.00% | -100.0% |
| Q1 2016 | $1,832,000 | +40.2% | 246,741 | +56.9% | 0.00% | +100.0% |
| Q4 2015 | $1,307,000 | -18.7% | 157,215 | -11.9% | 0.00% | -50.0% |
| Q3 2015 | $1,608,000 | -4.7% | 178,389 | +26.8% | 0.00% | +100.0% |
| Q2 2015 | $1,688,000 | +153.5% | 140,658 | +127.6% | 0.00% | – |
| Q1 2015 | $666,000 | +294.1% | 61,799 | +86.3% | 0.00% | – |
| Q4 2014 | $169,000 | +207.3% | 33,167 | +60.1% | 0.00% | – |
| Q3 2014 | $55,000 | -71.2% | 20,712 | -56.3% | 0.00% | – |
| Q2 2014 | $191,000 | +50.4% | 47,361 | +72.2% | 0.00% | – |
| Q1 2014 | $127,000 | -71.5% | 27,502 | -73.3% | 0.00% | – |
| Q4 2013 | $446,000 | +77.7% | 102,893 | +61.0% | 0.00% | – |
| Q3 2013 | $251,000 | +99.2% | 63,906 | +6.8% | 0.00% | – |
| Q2 2013 | $126,000 | – | 59,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |